Skip to content
Epiontis ID Logo
  • Technology
  • Applications
  • Resources
  • Contact
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
Filters

Exploring Biomarkers to Predict the Response to Immunotherapy-Based Combination Treatment in Hepatocellular Carcinoma Using Epiontis ID™

Reza Sedaghat2022-10-06T10:33:50-04:00Resources|

Read More

Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay

Carlos Bonilla2022-08-08T17:01:14-04:00Resources|

Read More

Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci

Carlos Bonilla2022-08-08T17:06:12-04:00Resources|

Read More

Biological Impact of Iberdomide in Patients With Active Systemic Lupus Erythematosus

Carlos Bonilla2022-08-19T16:19:48-04:00Resources|

Read More

Regulatory T-Cells and Associated Pathways in Metastatic Renal Cell Carcinoma (mRCC) Patients Undergoing DC-Vaccination and Cytokine-Therapy

Carlos Bonilla2022-08-08T17:11:33-04:00Resources|

Read More
  • Home
  • Technology
  • Applications
  • Resources
  • Contact
© Precision Medicine Group, LLC.
All Rights Reserved.
Privacy Policy GDPR



By continuing to use our website, you agree to our use of cookies to help us give you the best experience, analyze your site usage, and assist in our marketing efforts.
For more information, or to learn how to change your cookies preferences, please click here.

OK